Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIC-block with Lidocaine or Ropivacaine for closed reduction of distal radius fractures
2024-510572-20-00Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine + epinephrine and ropivacaine in distal forearm fracture (2 arms), sponsored by Nordsjællands Hospital. Primary endpoint: Incidence of successful blockade 45 minutes after block performance. Started Apr 2024; status: completed.
02
Drugs
lidocaine + epinephrineropivacaine
03
Conditions
distal forearm fracture
Beyond the preview
Go deeper on 2024-510572-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510572-20-00.